1<p>Groups of BALB/c mice (n = 5) were immunized three times subcutaneously with 3, 10, or 30 µg of D1ED III formulated with PELC plus CpG at two-week intervals. Naïve mice without immunization served as controls. All animals were inoculated intraperitoneally with 3×10<sup>6</sup> FFU of live dengue-1 virus at week 26 post-priming. Sera were collected at different time points as indicated. The sera's ability to neutralize dengue-1 virus was determined by FRNT. The neutralizing antibody titer was calculated as the reciprocal of the highest dilution that resulted in a 50% or 80% reduction of FFU compared to control samples containing the virus alone.</p>2<p>Statistical analysis was performed by the ANOVA Bonferroni post test at the same time ...
Serum obtained from mice 3 to 5 weeks after the third i.p. dose of dengue type 2 virus (DV) protecte...
<p>C57BL/6 mice were infected with 3×10<sup>4</sup> TCID<sub>50</sub> of ECTV intranasally. Mice wer...
<p>AG129 mice were immunized with 1×10<sup>6</sup> IU DENV2 E85-VRP i.p. 14 and 5 days prior to chal...
1<p>Mice were immunized with D1ED III (10 µg/dose) formulated with the indicated adjuvants three tim...
<p>BALB/c mice (n = 5) were immunized subcutaneously with 20 µg of cED III or LcED III two times at ...
<p>BALB/c mice (n = 5) were immunized once subcutaneously with 1, 5, or 20 µg of LcED III. (A) Seroc...
<p>Groups of BALB/c mice (n = 5) were immunized subcutaneously with 10 µg D2ED III or LD2ED III two ...
<p>Groups of 6- to 8-week-old BALB/c female mice (n = 6) were immunized three times at 2-week interv...
<p>Groups of 6- to 8-week-old BALB/c female mice (n = 6, except n = 4 for pVax-1) were immunized thr...
<p>Groups of BALB/c mice (n = 5) were immunized subcutaneously with 10 µg D2ED III or LD2ED III two ...
Background: Dengue is a global arboviral threat to humans; causing 390 million infections per year. ...
<p>Sera were collected from mice on days 0, 14, 28, 42, and 56. 25 µl of serial two-fold dilutions o...
Abstract. A dengue-2 (DEN-2) DNA vaccine coding for the premembrane and envelope (E) proteins and a ...
DNA vaccine against dengue is an interesting strategy for a prime/boost approach. This study evaluat...
Dengue virus (DENV) is the cause of dengue infection, an emerging infectious disease which has incre...
Serum obtained from mice 3 to 5 weeks after the third i.p. dose of dengue type 2 virus (DV) protecte...
<p>C57BL/6 mice were infected with 3×10<sup>4</sup> TCID<sub>50</sub> of ECTV intranasally. Mice wer...
<p>AG129 mice were immunized with 1×10<sup>6</sup> IU DENV2 E85-VRP i.p. 14 and 5 days prior to chal...
1<p>Mice were immunized with D1ED III (10 µg/dose) formulated with the indicated adjuvants three tim...
<p>BALB/c mice (n = 5) were immunized subcutaneously with 20 µg of cED III or LcED III two times at ...
<p>BALB/c mice (n = 5) were immunized once subcutaneously with 1, 5, or 20 µg of LcED III. (A) Seroc...
<p>Groups of BALB/c mice (n = 5) were immunized subcutaneously with 10 µg D2ED III or LD2ED III two ...
<p>Groups of 6- to 8-week-old BALB/c female mice (n = 6) were immunized three times at 2-week interv...
<p>Groups of 6- to 8-week-old BALB/c female mice (n = 6, except n = 4 for pVax-1) were immunized thr...
<p>Groups of BALB/c mice (n = 5) were immunized subcutaneously with 10 µg D2ED III or LD2ED III two ...
Background: Dengue is a global arboviral threat to humans; causing 390 million infections per year. ...
<p>Sera were collected from mice on days 0, 14, 28, 42, and 56. 25 µl of serial two-fold dilutions o...
Abstract. A dengue-2 (DEN-2) DNA vaccine coding for the premembrane and envelope (E) proteins and a ...
DNA vaccine against dengue is an interesting strategy for a prime/boost approach. This study evaluat...
Dengue virus (DENV) is the cause of dengue infection, an emerging infectious disease which has incre...
Serum obtained from mice 3 to 5 weeks after the third i.p. dose of dengue type 2 virus (DV) protecte...
<p>C57BL/6 mice were infected with 3×10<sup>4</sup> TCID<sub>50</sub> of ECTV intranasally. Mice wer...
<p>AG129 mice were immunized with 1×10<sup>6</sup> IU DENV2 E85-VRP i.p. 14 and 5 days prior to chal...